Skip to content

A study to assess the impact of 24 hour fermented millet Ambali powder with or without herbal kwatha in managing Type-2 Diabetes in elderly individuals

An exploratory comparative clinical study to assess the impact of 24-hour fermented millet Ambali powder with or without herbal kwatha in managing Type-2 Diabetes in elderly individuals - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082466
Enrollment
80
Registered
2025-03-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E11- Type 2 diabetes mellitus

Interventions

None listed

Sponsors

Organo Nutri
Lead Sponsor
Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Diabetes subjects of both sex of age group of 60-70 years. Fasting blood glucose level 121-250 mg/dL

Exclusion criteria

Exclusion criteria: Subjects with food allergy, chronic diseases or on life saving medication pregnant/ lactating women. smokers consuming more than 2 alcohol serving per week

Design outcomes

Primary

MeasureTime frame
24Hr. Fermented Millet Ambali Powder with or without Herbal Kwatha is effective in managing Type-2 Diabetes in elderly individuals.Timepoint: 24Hr. Fermented Millet Ambali Powder with or without Herbal Kwatha is effective in managing Type-2 Diabetes in elderly individuals.

Secondary

MeasureTime frame
24Hr. Fermented Millet Ambali Powder with or without Herbal Kwatha is effective in the reduction of blood sugar fasting level, Uric acid, HbA1C, increase in Vitamin B12 and changes in LFT, KFT and lipid profile parameters Safety RecordingTimepoint: 03 months

Countries

India

Contacts

Public ContactProf Harish Kumar Singhal

Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur

ayurharish14@gmail.com9636622206

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026